160 related articles for article (PubMed ID: 19351922)
1. Drugging the Wnt pathway: problems and progress.
Garber K
J Natl Cancer Inst; 2009 Apr; 101(8):548-50. PubMed ID: 19351922
[No Abstract] [Full Text] [Related]
2. Wnt signaling as a therapeutic target for cancer.
Herbst A; Kolligs FT
Methods Mol Biol; 2007; 361():63-91. PubMed ID: 17172707
[TBL] [Abstract][Full Text] [Related]
3. Mining the Wnt pathway for cancer therapeutics.
Barker N; Clevers H
Nat Rev Drug Discov; 2006 Dec; 5(12):997-1014. PubMed ID: 17139285
[TBL] [Abstract][Full Text] [Related]
4. Novel Wnt signaling and other pathway inhibitors in the colorectal cancer genomic landscape era.
Roukos DH; Ziogas DE; Papaloukas C; Baltogiannis G
Future Oncol; 2012 Nov; 8(11):1373-6. PubMed ID: 23148609
[No Abstract] [Full Text] [Related]
5. Cyclooxygenase-2 inhibitors down-regulate osteopontin and Nr4A2-new therapeutic targets for colorectal cancers.
Zagani R; Hamzaoui N; Cacheux W; de Reyniès A; Terris B; Chaussade S; Romagnolo B; Perret C; Lamarque D
Gastroenterology; 2009 Oct; 137(4):1358-66.e1-3. PubMed ID: 19549529
[TBL] [Abstract][Full Text] [Related]
6. Elevated Dnmt3a activity promotes polyposis in Apc(Min) mice by relaxing extracellular restraints on Wnt signaling.
Samuel MS; Suzuki H; Buchert M; Putoczki TL; Tebbutt NC; Lundgren-May T; Christou A; Inglese M; Toyota M; Heath JK; Ward RL; Waring PM; Ernst M
Gastroenterology; 2009 Sep; 137(3):902-13, 913.e1-11. PubMed ID: 19454286
[TBL] [Abstract][Full Text] [Related]
7. Recent Advances in Developmental Signaling Pathway Inhibitors for the Treatment of Cancer.
Hadden MK
Curr Med Chem; 2015; 22(35):4031-2. PubMed ID: 26630931
[No Abstract] [Full Text] [Related]
8. Targeting Wnt pathway in lymphoma and myeloma cells.
Schmidt M; Sievers E; Endo T; Lu D; Carson D; Schmidt-Wolf IG
Br J Haematol; 2009 Mar; 144(5):796-8. PubMed ID: 19036118
[No Abstract] [Full Text] [Related]
9. Hedgehog Wnteraction in colorectal cancer.
van den Brink GR; Hardwick JC
Gut; 2006 Jul; 55(7):912-4. PubMed ID: 16766747
[TBL] [Abstract][Full Text] [Related]
10. Apoptosis and colorectal cancer: implications for therapy.
Yang SY; Sales KM; Fuller B; Seifalian AM; Winslet MC
Trends Mol Med; 2009 May; 15(5):225-33. PubMed ID: 19362056
[TBL] [Abstract][Full Text] [Related]
11. Developing novel and highly effective new therapeutic strategies for treatment of colorectal cancer: where do we go from here?
Houghton JA
Curr Opin Investig Drugs; 2001 May; 2(5):674-6. PubMed ID: 11569946
[No Abstract] [Full Text] [Related]
12. PARsing the phrase "all in for Axin"- Wnt pathway targets in cancer.
Fearon ER
Cancer Cell; 2009 Nov; 16(5):366-8. PubMed ID: 19878868
[TBL] [Abstract][Full Text] [Related]
13. WNT signalling pathways as therapeutic targets in cancer.
Anastas JN; Moon RT
Nat Rev Cancer; 2013 Jan; 13(1):11-26. PubMed ID: 23258168
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, determination of stereochemistry, and evaluation of new bisindole alkaloids from the myxomycete Arcyria ferruginea: an approach for Wnt signal inhibitor.
Kaniwa K; Arai MA; Li X; Ishibashi M
Bioorg Med Chem Lett; 2007 Aug; 17(15):4254-7. PubMed ID: 17531487
[TBL] [Abstract][Full Text] [Related]
15. 2,4-Diamino-quinazolines as inhibitors of beta-catenin/Tcf-4 pathway: Potential treatment for colorectal cancer.
Chen Z; Venkatesan AM; Dehnhardt CM; Dos Santos O; Delos Santos E; Ayral-Kaloustian S; Chen L; Geng Y; Arndt KT; Lucas J; Chaudhary I; Mansour TS
Bioorg Med Chem Lett; 2009 Sep; 19(17):4980-3. PubMed ID: 19640711
[TBL] [Abstract][Full Text] [Related]
16. From cell signaling to cancer therapy.
Ding J; Feng Y; Wang HY
Acta Pharmacol Sin; 2007 Sep; 28(9):1494-8. PubMed ID: 17723182
[TBL] [Abstract][Full Text] [Related]
17. Wnt signalling in development and disease. Max Delbrück Center for Molecular Medicine meeting on Wnt signaling in Development and Disease.
Fuerer C; Nusse R; Ten Berge D
EMBO Rep; 2008 Feb; 9(2):134-8. PubMed ID: 18188179
[No Abstract] [Full Text] [Related]
18. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
Shan BE; Wang MX; Li RQ
Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
[TBL] [Abstract][Full Text] [Related]
19. Wnt/beta-catenin signaling regulates cytokine-induced human inducible nitric oxide synthase expression by inhibiting nuclear factor-kappaB activation in cancer cells.
Du Q; Zhang X; Cardinal J; Cao Z; Guo Z; Shao L; Geller DA
Cancer Res; 2009 May; 69(9):3764-71. PubMed ID: 19383900
[TBL] [Abstract][Full Text] [Related]
20. Wnt pathway: a new role in regulation of inflammation.
George SJ
Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):400-2. PubMed ID: 18296599
[No Abstract] [Full Text] [Related]
[Next] [New Search]
